What Innoopract does

Innoopract Informationssysteme GmbH is a privately held German software and services company founded in 1997 and headquartered in Karlsruhe, Germany. The company develops and licenses proprietary technology for regulated digital workflows, with a distributed team spanning six country locations and employees across eight countries. Innoopract operates two core technology platforms: Tabris.js, a cross-platform native mobile development framework for iOS, Android, and Windows with Runtime Self Protection security, and the Eclipse-based Remote Application Platform (RAP). It is a founding member of the Eclipse Foundation (the third German company after SAP and SuSe) and credits 150M+ Eclipse package downloads over a ten-year period.

The company's product portfolio targets three highly regulated verticals. In healthcare, diwoBlood provides a fully digital workflow for blood donation services (used by the Bavarian Red Cross and Austrian Red Cross), with companion donor-facing apps (diwoBlood Q) and a 2024 AI-based Mediform autonomous phone assistance solution for medical practices. In financial services, PSD2TAC provides two-factor Strong Customer Authentication for PSD2 compliance, with mobile banking apps developed for 1822direkt (winner of 1st place in CHIP magazine rating) and Finanz Informatik Solutions Plus. In regulatory technology, the company co-developed a cloud-native platform with Regnology Group GmbH. Sister companies EclipseSource and Tabris.com distribute enterprise tooling and mobile framework licensing respectively.

Revenue is generated through three streams: professional services (consulting, technical advisory, training, custom development), product licensing (diwoBlood, PSD2TAC, chatbot and digital signature modules), and technology framework licensing (Tabris.js). Pricing is custom and undisclosed, with contact-based sales indicative of enterprise/consultative go-to-market. Customers include large financial institutions, Red Cross blood donor services, medical compliance firms (Thieme Compliance), and industrial distributors, with distribution across direct enterprise sales, sister-company platforms, and consumer app stores.

Name

Innoopract

Legal name

Innoopract Informationssysteme GmbH

Website

https://innoopract.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

Innoopract is a German software and services company (founded 1997, Karlsruhe) that develops proprietary Eclipse-based and mobile (Tabris.js) technologies for regulated digital workflows, serving financial services, blood donation/Red Cross, and medical practice customers with products like diwoBlood, PSD2TAC, and Mediform.

Ownership category

akta.pro rank

Product category

Enterprise Software Development Tools

NAICS

Software Publishers (5132), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)

akta.pro primary industry

API Management & Developer Portals for Health Data (HLACABAD)

Keywords

• Eclipse software development
• Mobile application framework
• Blood donation management
• PSD2 authentication software
• Enterprise consulting services

Headquarters

HQ city

Karlsruhe

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Professional Services: Consulting and technical advisory services, developer support packages, training, and custom development. Services include digitalization of processes, product development, and technical due diligence.
2. Product Licensing: Sale and licensing of software products including diwoBlood, PSD2TAC, and chatbot modules. Products are extensible and adaptable to meet unique customer needs.
3. Technology Framework Licensing: Tabris.js framework licensing for mobile app development. EclipseSource provides support for Eclipse-based tools and multi-platform solutions.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Innoopract develops and licenses proprietary vertical software products — diwoBlood for blood donor management, PSD2TAC for PSD2-compliant strong customer authentication, Mediform for digital medical forms and patient consent, Tabris.js for cross-platform mobile apps, J2V8 for embedding JavaScript in Java, and EclipseSource (RAP) for web application development — and supplements them with consulting, training and custom development services targeting regulated industries.

Product overview

Innoopract is a software and service company offering a portfolio of proprietary products for highly regulated markets (finance and healthcare) combined with technology platforms. The core products include diwoBlood (digital blood donation workflow software), PSD2TAC (Strong Customer Authentication mobile app), and Mediform (AI-based digital reception for medical practices). These products share a common technology core built on Tabris.js and Eclipse frameworks. The company also offers modular components - Chatbot and Digital Signature modules - that can be embedded in existing applications. Additionally, Innoopract maintains Eclipse-based technology platforms (RAP, RCP, JSON Forms) and operates EclipseSource as a division supporting enterprise tooling development.

Differentiator

Problem solved

Functional benefit

Products and services

• diwoBlood

Quantifiable outcome

• 1822direkt Banking App won 1st place in CHIP magazine app rating for online banking security
• +2 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature7 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Regnology Group GmbHcoreStrategic or Co-development PartnerInnoopract worked with Regnology to develop a cloud-native software platform for regulators across the globe. The project succeeded with a 'greenfield' approach using architecture not previously familiar to Innoopract, achieving data load handling performance not seen in the market before.
• Thieme CompliancecoreStrategic or Co-development PartnerThieme Compliance's E-ConsentPro mobile product incorporates diwoBlood apps for anamnesis and consultation. This partnership provides clinically proven mobile apps for electronic patient education, developed in cooperation with blood donation services.
• 1822direktcoreStrategic or Co-development PartnerCo-development partnership resulting in banking app that won 1st place in CHIP magazine rating. The 1822direkt Banking App was developed using Tabris technology and achieved best-in-class security rating.
• BearingPointminorGTM or Marketing PartnerBearingPoint is listed as a partner of Innoopract, specifically mentioned in the context of PSD2TAC product partnership.
• ThalesminorGTM or Marketing PartnerThales is shown as a logo partner on the Innoopract website homepage.
• EnBWminorGTM or Marketing PartnerEnBW is shown as a logo partner on the Innoopract website homepage.
• ThiememinorGTM or Marketing PartnerThieme is shown as a logo partner on the Innoopract website homepage (distinct from Thieme Compliance).
• Blood Donor Service of the Bavarian Red CrosscoreStrategic or Co-development PartnerCooperation with Blood Donor Service of the Bavarian Red Cross to optimize diwoBlood apps for the blood donation process. Partnership included three parallel tests proving maturity and stability of the mobile solution.
• Austrian Red Cross, Blood Transfusion Service for Upper AustriacoreStrategic or Co-development PartnerPartnership for seamless integration of digital health questionnaire into system environment. Austrian Red Cross recognized Innoopract as a competent partner for digital transformation.

Scale indicators6 records

Recent moves6 records

Expansion highlights11 records

Broad incumbents

• OutSystems: Enterprise low-code platform enabling rapid app development across web and mobile; overlaps with Innoopract's RAP/single-sourcing value proposition for regulated industries.
• Appian: Low-code automation platform with strong footprint in regulated industries (financial services, healthcare/government) — a comparable incumbent to Innoopract's verticalized enterprise model.
• Mendix: Low-code development platform (Siemens-owned) targeting enterprise digital transformation — directly comparable to Innoopract's regulated-market, extended-support positioning.
• Progress Software: Long-established developer-tools and application-lifecycle vendor with overlapping enterprise and regulated-industry customers; comparable on the 'extended-support, framework-lifecycle' angle.

Direct peers

• Ionic: Cross-platform mobile and web app framework serving enterprise developers; the most direct Tabris.js competitor in the JavaScript-based native-UI mobile space.
• EclipseSource: Sister company under common ownership with overlapping Eclipse tooling and developer-relations focus. Both provide advanced tooling, multi-platform, and modeling solutions to enterprise customers.

Emerging players

• OneSpan: Digital identity and anti-fraud authentication vendor with deep PSD2/SCA offering for European banks — overlaps with PSD2TAC's regulatory positioning and target buyer.
• Nok Nok Labs: Strong-customer-authentication and FIDO-based authentication specialist serving PSD2 compliance — the closest comparable to Innoopract's PSD2TAC product line in the EU banking market.
• FACT Solutions (M-Power): German vendor of blood-bank and blood-donation management software; the most direct competitor to Innoopract's diwoBlood product line in the DACH healthcare market.

Others

• Red Hat: Steward of the broader open-source/Java ecosystem that Innoopract's Eclipse tooling ecosystem depends on; comparable as ecosystem participant rather than direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/innoopract
• LinkedInlinkedin.com/company/innoopract

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innoopract